| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 108.626 | 85.399 | 80.268 | 81.535 | 79.741 | 107.847 | 185.079 | 34.103 | 52.822 | 28.209 |
| Total Income - EUR | 103.533 | 85.480 | 80.830 | 82.832 | 82.383 | 107.903 | 185.168 | 34.404 | 52.978 | 28.913 |
| Total Expenses - EUR | 63.240 | 46.997 | 35.802 | 55.751 | 49.870 | 35.087 | 58.140 | 21.926 | 25.865 | 17.350 |
| Gross Profit/Loss - EUR | 40.292 | 38.483 | 45.028 | 27.082 | 32.513 | 72.817 | 127.028 | 12.478 | 27.114 | 11.563 |
| Net Profit/Loss - EUR | 33.722 | 32.214 | 43.946 | 26.266 | 31.715 | 71.776 | 125.177 | 12.137 | 26.586 | 11.281 |
| Employees | 1 | 1 | 1 | 2 | 2 | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Bioimpex Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 330 | 5.794 | 4.911 | 4.050 | 3.215 | 2.413 | 8.006 | 6.000 | 3.957 | 2.562 |
| Current Assets | 192.223 | 123.589 | 143.853 | 136.095 | 140.589 | 149.567 | 257.966 | 117.425 | 131.548 | 119.681 |
| Inventories | 3.618 | 3.983 | 3.916 | 3.844 | 3.769 | 3.698 | 3.616 | 3.627 | 3.616 | 704 |
| Receivables | 169.034 | 115.391 | 115.974 | 103.188 | 129.901 | 133.622 | 244.044 | 104.577 | 125.883 | 115.587 |
| Cash | 19.571 | 4.214 | 23.964 | 29.063 | 6.919 | 12.248 | 10.306 | 9.221 | 2.049 | 3.391 |
| Shareholders Funds | 181.153 | 117.245 | 131.390 | 112.946 | 120.736 | 138.761 | 260.867 | 118.528 | 128.274 | 120.907 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 11.400 | 12.138 | 17.374 | 27.198 | 23.068 | 13.219 | 5.106 | 4.897 | 7.231 | 1.336 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "128 - 128" | |||||||||
| CAEN Financial Year |
129
|
|||||||||
Comments - Bioimpex Srl